3 Mid-Year Mid-Cap Biotech Picks
“All three picks can be volatile but very tradable and should be considered as long term holds with expectations for growth, positive clinical data or M&A.”
“All three picks can be volatile but very tradable and should be considered as long term holds with expectations for growth, positive clinical data or M&A.”
Small- And Mid-Cap Biotech Picks For 2021 and holdovers from 2020.